MarkWide Research

Sale!

Thyroid Gland Disorders Treatment Market Analysis 2022-2030

Published Date: June, 2022
No of Pages: 169
Delivery Format: PDF+ Excel

$2,950.00

Thyroid Gland Disorders Treatment Market

The demand for Thyroid Gland Disorders Treatment Market is driven by the growing burden of people suffering from iodine deficiency. One of the main reasons for iodine deficiency is the lack of adequate sources of iodine found in the diet. According to the World Health Organization (WHO), iodine’s recommended intake (RDI) is 150 milligrams per day. This is enough for more than 95 percent of healthy adults, including lactating and pregnant women requiring more.

Iodine deficiency is becoming more common across European countries and the middle- and low-income countries of Asia-Pacific and Africa. The National Institute of Health has said that the prevalence of iodine deficiencies is higher in the mountains located in the United States and Mexico, where more sufferers are suffering from thyroid disorders. Furthermore, the increase in the smoking of tobacco and alcohol is also causing thyroid problems in developing regions. It is one of the main drivers of the market being studied.

thyroid gland disorders treatment market

Get more information on this report : Download Free Sample Pages

The scope Thyroid Gland Disorders Treatment Market report

Key Market Segments

  • BY DISEASE TYPE
    • Hypothyroidism
    • Hyperthyroidism
  • BY DRUG TYPE
    • Levothyroxine
    • Liothyronine
    • Propylthiouracil
    • Imidazole-based compounds
    • Others
  • BY ROUTE OF ADMINISTRATION
    • Oral
    • Intravenous route
    • Others
  • BY DISTRIBUTION CHANNEL
    • Wholesaler/Distributor Retailer Mail-order Pharmacy Others
    • Retailer
    • Mail-Order Pharmacy
    • Others

The inability of the thyroid gland to make enough thyroid hormones results in different thyroid gland-related diseases.

Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

The Hyperthyroidism Market is expected to see Rapid Increase.

Hyperthyroidism is a disease that occurs when your thyroid gland makes thyroxin, a hormone in excess. According to the National Institute of Health, the estimated prevalence of the disease is about 1-1.3 percent. It grows to 4 to 5 percent when women are older. Furthermore, the disease most often occurs in smokers.

Because smoking is on the rise in people across the globe, a growing number of people are becoming victims of the illness. Additionally, awareness of hyperthyroidism is growing in developing nations like India and China, increasing the size of the market being studied. Further, the ease of access to antithyroid drugs for hyperthyroidism has fueled the demand.

thyroid gland disorders treatment market

Customize this report as per your requirement

North America will Dominate the Thyroid Gland Disorders Treatment Market

According to estimates, around 35 million people across North America suffer from at least one type of thyroid illness. Numerous companies have collaborated with ATA (America Thyroid Association) because the organization has provided research grants that amount to around $ 2.2 million. Furthermore, multinational companies frequently raise awareness in American society by launching campaigns.

For example, Merck launched the “It is not you. It’s Your Thyroid” campaign in 2017 and 2018. Its annual “Awareness” campaign is conducted in partnership with Thyroid Federation International (TFI). It is based on the observation by many companies that thyroid disorders aren’t fully recognized and are often misdiagnosed. The growing health infrastructure and extensive government involvement in treating thyroid disorders make North America a significant revenue contribution to the market being studied.

The market for treatment for thyroid gland disorders is competitive but mainly comprises global players. The rapid advancements in therapies could see the entry of some minor or mid-sized businesses into the market shortly.

Major Players of Thyroid Gland Disorders Treatment Market Report:

  1. Abbvie Inc.
  2. Merck KGaA
  3. Mylan NV
  4. Pfizer Inc.
  5. Exelixis Inc.
  6. Others
Research Approach/Methodology of Thyroid Market Report

MWR’s research methodology is based on extensive use of secondary and primary data sources. The research involves the analysis of various aspects impacting the industry, including the policies of the government, the competitive landscape, the market environment and historical data, as well as current developments in the market technological innovation, emerging technologies, and the advancement of technology in related industries, and potential market risks as well as market barriers and issues.

Market Size Estimation of Thyroid Gland Disorders Treatment Market

Bottom-up and top-down approaches are employed to verify the size of the global product market and to estimate the size of the Thyroid Gland Disorders Treatment Market for companies’ regions, regions segment as well as product segments and applications (end users). The market estimates are built on the product’s retail price (excluding discounts offered by the distributor, manufacturer, wholesaler, trader, or).

Partially splits, market shares and breakdown of product segments are calculated based on the weights allocated to each segment based on their usage rate and average sale price. The regional splits of the total product market and sub-segments are determined by the per cent of adoption or use of the particular product within the specific region or country.

Top key players of the Thyroid Gland Disorders Treatment Market is determined through secondary data, and the market revenue is determined by secondary and primary approach. Secondary research comprised the study of financial and annual reports of the largest companies. In contrast, primary research involved extensive interviews with opinion makers and experts in the industry like experienced front-line employees, directors, CEOs, and marketing managers.

The market share, percentage splits and Growth Rate, as well as the market structure of the Thyroid Gland Disorders Treatment Market, are calculated from secondary sources and then verified by primary sources. All potential factors that affect the markets are verified by conducting primary analysis, and then analyzed to obtain the final qualitative and quantitative results.

Market Breakdown, Data and Triangulation of Thyroid Gland Disorders Treatment Market

After completing market engineering, including calculations of market statistics, size estimations, forecasting of market breakdown, and data triangulation, a lot of analysis are then conducted to collect details and to confirm the numbers to be verified.

Throughout the entire method of market engineering, top-down and bottom-up methods are were widely used, together with a variety of triangulation techniques for market estimation and forecasting of market trends for the entire market segment and sub-segments . A thorough analysis of quantitative data is also carried out using all the data gathered during the entire market engineering process to present important information throughout the Thyroid Gland Disorders Treatment Market research.

Data Sources of Thyroid Gland Disorders Treatment Market

Secondary Sources

Secondary sources include annual reports, press releases, non-profit organizations and industry associations, government agencies, customs information, and others. This study focuses on extensive use of secondary sources, directories, databases, and directories like Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones and Company) and trading ECONOMICS and News Network, Statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS and company house documents CAS (American Chemical Society) and investor presentations along with SEC filings of corporations.

Secondary research are utilized to discover and gather details that could be used for a thorough technological, market-oriented and commercial analysis of the product market. It also helps collecting necessary information on the most prominent companies, market classification and segmentation by market trends from the lowest level, and critical technological and market developments.

Primary Sources

For the research process, different sources from both the demand and supply sides are being interviewed to collect quantitative and qualitative information. The primary sources on the supply side comprise companies (and their rivals) and opinion leaders, experts from the industry and research institutes, distributors, traders and dealers, raw material suppliers and producers, etc.

The primary sources for demand-side information are industry experts, such as business leaders, sales and marketing directors, directors of innovation and technology supply chain executives, the market (product buyers) and top executives from a variety of key organizations and companies operating globally.

The primary studies are then conducted to find segments, types of segmentation, price ranges, application of the product important company, raw materials supply and demand downstream as well as the status of the industry and its forecast, and the fundamental market dynamics, such as risk factors, influence factors and opportunities obstacles to market entry, trends in the industry, and the strategies of key players.

COVID-19 impact Analysis of Thyroid Gland Disorders Treatment Market

To understand the impact of COVID, we must understand the supply chain of the industry and the value chain. By analysing the supply chain, we understand the bottlenecks affecting the industry’s growth. And by analysing the value chain, we understand what value each component adds to the entire industry. We then try to understand the COVID impact has on the industry by trying to find answers to the following questions: 

How many jobs have been lost?

How many people have died due to COVID?

How did the Government respond, and what measures Government has taken to revive a Thyroid Gland Disorders Treatment Market industry?

How companies in the Thyroid Gland Disorders Treatment Market have responded to COVID?

What growth rate companies are expecting in the Thyroid Gland Disorders Treatment Market ?

We also analyse their annual reports and press releases to understand their
strategies post COVID. Then we move towards the primary research part and contact government officials and industry experts such as CEOs, COOs, Directors, VPs, Directors and Managers to understand what impact COVID has had on their businesses and what they are doing to cope with it.

We also try to understand their views regarding other financial aspects, such as recovery and obstacles in achieving pre-COVID growth and when they expect to achieve it.

Finally, after gathering the info from secondary and primary research, we try to form a model through which we gauge the COVID impact on a particular industry (Thyroid Gland Disorders Treatment Market).

Table of Content

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Patient Population with Iodine Deficiency

      2. 4.2.2 Rising Government Initiatives for Thyroid Gland Screening and Treatment

    3. 4.3 Market Restraints

      1. 4.3.1 Unfavourable Healthcare Reforms in Some Regions

      2. 4.3.2 Alternative Herbal and Acupuncture Therapies

    4. 4.4 Porter’s Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Disorder

      1. 5.1.1 Hypothyroidism

      2. 5.1.2 Hyperthyroidism

      3. 5.1.3 Other Types of Disorder

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Parenteral

      3. 5.2.3 Other Routes of Administration

    3. 5.3 By Drug Class

      1. 5.3.1 Thioamides

      2. 5.3.2 Ionic Inhibitors

      3. 5.3.3 Hormone-release Inhibitors

      4. 5.3.4 Other Drug Classes

    4. 5.4 By Distribution Channel

      1. 5.4.1 Wholesale Distribution

      2. 5.4.2 Retail Stores

      3. 5.4.3 Online Pharmacy

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East & Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East & Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

      1. 6.1 Company Profiles

        1. 6.1.1 Abbvie Inc.

        2. 6.1.2 Amgen Inc.

        3. 6.1.3 GlaxoSmithKline PLC

        4. 6.1.4 Merck KGaA

        5. 6.1.5 Mylan NV

        6. 6.1.6 Novartis AG

        7. 6.1.7 Pfizer Inc.

        8. 6.1.8 Takeda Pharmaceutical Company Limited

        9. 6.1.9 Elexis Inc.

        10. 6.1.10 IBSA Pharma (IBSA Group)

    *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Segmentation

  • BY DISEASE TYPE
    • Hypothyroidism
    • Hyperthyroidism
  • BY DRUG TYPE
    • Levothyroxine
    • Liothyronine
    • Propylthiouracil
    • Imidazole-based compounds
    • Others
  • BY ROUTE OF ADMINISTRATION
    • Oral
    • Intravenous route
    • Others
  • BY DISTRIBUTION CHANNEL
    • Wholesaler/Distributor Retailer Mail-order Pharmacy Others
    • Retailer
    • Mail-Order Pharmacy
    • Others

Major Companies

  1. Merck KGaA
  2. Mylan NV
  3. Exelixis Inc.
  4. Abbott Laboratories
  5. AbbVie Inc
  6. Allergan Plc
  7. GlaxoSmithKline plc
  8. Lannett Company, Inc
  9. Novartis AG
  10. Pfizer Inc
  11. RLC LABS, Inc
  12. Others

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF